RxDoctor Payments Data

Robert Balkan, MD

Ophthalmology · New Orleans, LANPI 1790725737

Payments from drug & device makers

$561in general payments, 2019–2025

Across 10 payments — averaging $56.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Carl Zeiss Meditec USA, Inc.$196
  • Johnson & Johnson Surgical Vision, Inc.$118
  • Omeros Corporation$79
  • Apellis Pharmaceuticals, Inc.$48
  • Johnson & Johnson Vision Care, Inc.$29
  • Oyster Point Pharma, Inc.$22
  • plus $69 from 4 others

What the payments were for

  • Food & beverage$561100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$561 in reported general payments places this provider in the 25th percentile of 286 ophthalmology providers in Louisiana.

See all ophthalmology providers in Louisiana

Medicare billing

Part B allowed, 2024
$14,464
Medicare patients
92
Services billed
163

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Travoprost12$1,436
Tobramycin-DexamethasoneTobramycin/Dexamethasone11$605
Latanoprost55$434

Paid to pharmacies, not to this prescriber.

Other ophthalmology in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →